Tenax Therapeutics Statistics

Total Valuation

TENX has a market cap or net worth of $859.62 million. The enterprise value is $747.93 million.

Market Cap	859.62M
Enterprise Value	747.93M

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026, before market open.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

TENX has 58.88 million shares outstanding. The number of shares has increased by 156.80% in one year.

Current Share Class	25.78M
Shares Outstanding	58.88M
Shares Change (YoY)	+156.80%
Shares Change (QoQ)	+2.96%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	13.90%
Float	17.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.60
P/TBV Ratio	8.71
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.56

Current Ratio	14.56
Quick Ratio	13.63
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -55.64% and return on invested capital (ROIC) is -37.28%.

Return on Equity (ROE)	-55.64%
Return on Assets (ROA)	-35.08%
Return on Invested Capital (ROIC)	-37.28%
Return on Capital Employed (ROCE)	-58.09%
Weighted Average Cost of Capital (WACC)	10.78%
Revenue Per Employee	n/a
Profits Per Employee	-$3.29M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +151.72% in the last 52 weeks. The beta is 1.19, so TENX's price volatility has been higher than the market average.

Beta (5Y)	1.19
52-Week Price Change	+151.72%
50-Day Moving Average	13.73
200-Day Moving Average	10.01
Relative Strength Index (RSI)	52.10
Average Volume (20 Days)	602,143

Short Selling Information

The latest short interest is 194,456, so 0.33% of the outstanding shares have been sold short.

Short Interest	194,456
Short Previous Month	172,743
Short % of Shares Out	0.33%
Short % of Float	1.13%
Short Ratio (days to cover)	0.43

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-56.39M
Pretax Income	-52.60M
Net Income	-52.60M
EBITDA	n/a
EBIT	-56.39M
Earnings Per Share (EPS)	-$1.34

Full Income Statement

Balance Sheet

The company has $97.57 million in cash and n/a in debt, giving a net cash position of $97.57 million or $1.66 per share.

Cash & Cash Equivalents	97.57M
Total Debt	n/a
Net Cash	97.57M
Net Cash Per Share	$1.66
Equity (Book Value)	97.07M
Book Value Per Share	2.29
Working Capital	97.07M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-35.80M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	-35.80M
FCF Per Share	-$0.61

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TENX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-156.80%
Shareholder Yield	-156.80%
Earnings Yield	-6.22%
FCF Yield	-4.23%

Analyst Forecast

The average price target for TENX is $29.67, which is 103.22% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$29.67
Price Target Difference	103.22%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 3, 2024. It was a reverse split with a ratio of 1:80.

Last Split Date	Jan 3, 2024
Split Type	Reverse
Split Ratio	1:80

Scores

Altman Z-Score	n/a
Piotroski F-Score	1